Literature DB >> 28223891

What Should We Tell Our Patients About Marijuana (Cannabis indica and Cannabis sativa)?

Joseph Pizzorno.   

Abstract

With several states allowing medicinal use of marijuana and a growing number decriminalizing recreational use, many of our patients are using this herbal drug. Approximately 43% of US adults have tried marijuana, with 13% using it regularly. These users are seeking help from integrative medicine practitioners regarding safety. They are looking for advice based on research and clinical experience, not politics or philosophical bias. The major health problems caused by marijuana appear to be bronchial irritation, decreased motivation, learning difficulties, and injuries. However, less well appreciated are the toxicity problems caused by contamination with pesticides and solvent residues. We have important guidance to help prevent unnecessary toxicity in our patients who choose to use marijuana. This editorial reviews toxicity and safety. Medicinal use will be addressed in the future.

Entities:  

Year:  2016        PMID: 28223891      PMCID: PMC5312838     

Source DB:  PubMed          Journal:  Integr Med (Encinitas)        ISSN: 1546-993X


  42 in total

1.  Dose-related neurocognitive effects of marijuana use.

Authors:  K I Bolla; K Brown; D Eldreth; K Tate; J L Cadet
Journal:  Neurology       Date:  2002-11-12       Impact factor: 9.910

Review 2.  Respiratory and immunologic consequences of marijuana smoking.

Authors:  Donald P Tashkin; Gayle C Baldwin; Theodore Sarafian; Steven Dubinett; Michael D Roth
Journal:  J Clin Pharmacol       Date:  2002-11       Impact factor: 3.126

3.  Potential exposures associated with indoor marijuana growing operations.

Authors:  John W Martyny; Kate A Serrano; Joshua W Schaeffer; Mike V Van Dyke
Journal:  J Occup Environ Hyg       Date:  2013       Impact factor: 2.155

Review 4.  The "new" marijuana.

Authors:  Daina L Wells; Carol A Ott
Journal:  Ann Pharmacother       Date:  2011-02-15       Impact factor: 3.154

5.  Hepatitis B in Nuremberg, Germany. Epidemiology of a drug-associated epidemic. Among US Army soldiers.

Authors:  W Cates; J W Warren
Journal:  JAMA       Date:  1975-12-01       Impact factor: 56.272

Review 6.  Pharmacotherapies for cannabis dependence.

Authors:  Kushani Marshall; Linda Gowing; Robert Ali; Bernard Le Foll
Journal:  Cochrane Database Syst Rev       Date:  2014-12-17

Review 7.  Clinical trials of N-acetylcysteine in psychiatry and neurology: A systematic review.

Authors:  John Slattery; Nihit Kumar; Leanna Delhey; Michael Berk; Olivia Dean; Charles Spielholz; Richard Frye
Journal:  Neurosci Biobehav Rev       Date:  2015-05-06       Impact factor: 8.989

8.  Analysis of cannabinoids in laser-microdissected trichomes of medicinal Cannabis sativa using LCMS and cryogenic NMR.

Authors:  Nizar Happyana; Sara Agnolet; Remco Muntendam; Annie Van Dam; Bernd Schneider; Oliver Kayser
Journal:  Phytochemistry       Date:  2012-12-29       Impact factor: 4.072

Review 9.  [Delta-9-tetrahydrocannabinol pharmacokinetics].

Authors:  J-P Goullé; E Saussereau; C Lacroix
Journal:  Ann Pharm Fr       Date:  2008-08-29

10.  Salmonellosis associated with marijuana: a multistate outbreak traced by plasmid fingerprinting.

Authors:  D N Taylor; I K Wachsmuth; Y H Shangkuan; E V Schmidt; T J Barrett; J S Schrader; C S Scherach; H B McGee; R A Feldman; D J Brenner
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

View more
  1 in total

1.  Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects.

Authors:  Laura M Dryburgh; Nanthi S Bolan; Christopher P L Grof; Peter Galettis; Jennifer Schneider; Catherine J Lucas; Jennifer H Martin
Journal:  Br J Clin Pharmacol       Date:  2018-08-01       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.